Atra stock forecast.

High Growth Earnings: ATRA is forecast to remain unprofitable over the next 3 years. Revenue vs Market: ATRA's revenue (44.8% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: ATRA's revenue (44.8% per year) is forecast to grow faster than 20% per year.

Atra stock forecast. Things To Know About Atra stock forecast.

Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...Should You Buy or Sell Atara Biotherapeutics Stock? Get The Latest ATRA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.Jun 30, 2023 · ATRA stock forecast for 2023 – 2027. Last updated: January 22, 2023. ATRA. Atara Biotherapeutics, Inc. 3.89 D 9.58% (0.34) Are you interested in Atara Biotherapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ATRA stock price in 2022-2027. Is ATRA a good long term stock? Nov 16, 2023 · It follows that stock’s current price would drop -7268.42% in reaching the projected high whereas dropping to the targeted low would mean a loss of -31.58% for stock’s current value. Atara Biotherapeutics Inc (ATRA) estimates and forecasts

Earnings Date. Feb 06, 2024 - Feb 12, 2024. Forward Dividend & Yield. N/A (N/A) Ex-Dividend Date. N/A. 1y Target Est. 3.94. Fair Value is the appropriate price for the shares of a company, based ... ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period. See TATA STEEL LTD stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Forecast . Options . Price target. 131.74 0.00 0.00%. The 27 analysts offering 1 year price forecasts for TATASTEEL have a max estimate of — and a min estimate of —.

KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62.According to the issued ratings of 4 analysts in the last year, the consensus rating for Atara Biotherapeutics stock is Hold based on the current 3 hold ratings and 1 buy rating for ATRA. The average twelve-month price prediction for Atara Biotherapeutics is $28.00 with a high price target of $31.00 and a low price target of $25.00.

Stock Price Forecast. The 15 analysts offering 12-month price forecasts for Rolls-Royce Holdings PLC have a median target of 10.14, with a high estimate of 15.24 and a low estimate of 3.58. The ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for ATRA stock stock is $12.15, which predicts an increase of 1,655.27%. The lowest target is $0.50 and the highest is $25. On average, analysts rate ATRA stock stock as a hold.Atara Biotherapeutics Stock Forecast, "ATRA" Share Price Prediction Charts Is "Atara Biotherapeutics Inc" a Good Investment? Current price today: 0.650 USD (+2.331%) …Stock Price Forecast. According to 33 stock analysts, the average 12-month stock price forecast for Apple stock is $197.09, which predicts an increase of 3.05%. The lowest target is $120 and the highest is $240. On average, analysts rate Apple stock as …

Analyst projections state that ATRA is forecast to be at a low of $1.40 and a high of $31.00. In order for the stock price to hit the forecast high, the stock would need to plunge -2248.48% from its current level, while the stock would need to crash -6.06% from its current level to reach the projected low.

The average Li Cycle Holdings stock price prediction forecasts a potential upside of 484.05% from the current LICY share price of $0.70. What is LICY's forecast return on equity (ROE) for 2023-2025? (NYSE: LICY) forecast ROE is …

15 analysts have issued 12-month price objectives for Boeing's stock. Their BA share price targets range from $200.00 to $300.00. On average, they expect the company's stock price to reach $249.38 in the next year. This suggests a possible upside of 13.4% from the stock's current price.Nov 23, 2023 · High Growth Earnings: ATRA is forecast to remain unprofitable over the next 3 years. Revenue vs Market: ATRA's revenue (44.8% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: ATRA's revenue (44.8% per year) is forecast to grow faster than 20% per year. Microsoft Corp Revenue Forecast for 2023 - 2025 - 2030. In the last four years, Microsoft Corp's Revenue has grown by 57.55%, rising from $125.84B to $198.27B. For next year, analysts predict Revenue of $257.87B, which would mean an increase of 30.06%. Over the next seven years, experts predict that Microsoft Corp's Revenue will …Analyst projections state that ATRA is forecast to be at a low of $0.40 and a high of $28.00. In order for the stock price to hit the forecast high, the stock would need to plunge -4207.69% from its current level, while the stock would need to crash 38.46% from its current level to reach the projected low.Stock Price Forecast. The 2 analysts offering 12-month price forecasts for BioLine RX Ltd have a median target of 14.30, with a high estimate of 21.00 and a low estimate of 7.60. The median ...Atara Biotherapeutics Inc (ATRA) stock experienced a significant surge today following the release of optimistic price forecasts from analysts. With a median target of $20.00, the stock is expected to witness a staggering 1,165.82% increase from its last closing price of $1.58.

HRTX Stock 12 Months Forecast. $9.00. (1402.00% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Heron Therapeutics in the last 3 months. The average price target is $9.00 with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 1402.00% change from the last price of $0.60.Oct 27, 2023 · Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions. According to analyst projections, ATRA’s forecast low is $0.50 with $28.00 as the target high. To hit the forecast high, the stock’s price needs a -5500.0% plunge from its current level, while the stock would need to tank 0.0% for it to hit the projected low. Atara Biotherapeutics Inc (ATRA) estimates and forecastsUnlock tomorrow's (ATRA) stock trends with our detailed analysis. Get insights on Atara Biotherapeutics, Inc.'s performance, backed by data-driven predictions for informed investment.ZIM Integrated Shipping Services (NYSE:ZIM) pays an annual dividend of $9.35 per share and currently has a dividend yield of 134.73%. ZIM has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for ZIM.According to analyst projections, ATRA’s forecast low is $0.50 with $28.00 as the target high. To hit the forecast high, the stock’s price needs a -5500.0% plunge from its current level, while the stock would need to tank 0.0% for it to hit the projected low. Atara Biotherapeutics Inc (ATRA) estimates and forecasts

According to our current ATRA stock forecast, the value of Atara Biotherapeutics shares will rise by 5.88% and reach $ 1.826488 per share by October 16, 2023. According to our …

25 Wall Street analysts have issued 1 year price objectives for Pioneer Natural Resources' stock. Their PXD share price targets range from $236.00 to $332.00. On average, they anticipate the company's share price to reach $258.45 in the next twelve months. This suggests a possible upside of 11.3% from the stock's current price.7 equities research analysts have issued 12-month price targets for Luminar Technologies' stock. Their LAZR share price targets range from $3.00 to $20.00. On average, they expect the company's stock price to reach $11.71 in the next twelve months. This suggests a possible upside of 376.2% from the stock's current price.Stock Price Forecast. The 2 analysts offering 12-month price forecasts for BioLine RX Ltd have a median target of 14.30, with a high estimate of 21.00 and a low estimate of 7.60. The median ...Atara Biotherapeutics Inc. 0.51. Delayed Data. As of Nov 17. +0.0295 / +6.14%. Today’s Change. 0.20. Today ||| 52-Week Range. 5.64.This page offers a collection of popular stock exchanges and their most prominent stocks for which our website offers price predictions. Clicking on names of the stocks will bring you to the price forecasts, while choosing the stock market will list the available stocks on the market. Vanguard Group, Inc. - Vanguard Energy ETF Pakistan ...The Trade Desk, Inc. (NASDAQ:TTD) issued its quarterly earnings data on Thursday, November, 9th. The technology company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.13 by $0.05. The technology company had revenue of $493.27 million for the quarter, compared to the consensus estimate of ...CYBN Stock 12 Months Forecast. $5.50. (1067.48% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cybin in the last 3 months. The average price target is $5.50 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 1067.48% change from the last price of $0.47.13 brokerages have issued 1 year price objectives for Abbott Laboratories' stock. Their ABT share price targets range from $102.00 to $133.00. On average, they predict the company's share price to reach $117.47 in the next year. This suggests a possible upside of 14.2% from the stock's current price.

We feed our Machine Learning (AI based) forecast algorithm data from the most influential global exchanges. There are a number of existing AI-based platforms that try to predict the future of Stock markets. They include data research on historical volume, price movements, latest trends and compare it with the real-time performance of the market.

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.

ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period. Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...The latest Atara Biotherapeutics stock prices, stock quotes, news, and ATRA history to help you invest and trade smarter. ... The 18 analysts offering price forecasts for Atara Biotherapeutics ...Real time Atara Biotherapeutics (ATRA) stock price quote, stock graph, news & analysis.500. Check out the ideas and forecasts on stocks from top authors of our community. They share predictions and technical outlook of the market to find trending stocks of different countries: India, USA, UK, Japan, etc. Join our financial community to start learning more about the markets. — India.Tilray Stock Forecast 12-10-2023. Forecast target price for 12-10-2023: $ 1.86. Negative dynamics for Tilray shares will prevail with possible volatility of 11.482%. Pessimistic target level: 1.72. Optimistic target level: 1.94.

The OptiNose Inc. stock price gained 1.63% on the last trading day (Wednesday, 29th Nov 2023), rising from $1.23 to $1.25. During the last trading day the stock fluctuated 4.02% from a day low at $1.21 to a day high of $1.26. The price has risen in 6 of the last 10 days.In this article, we answer “what is sales forecasting?” by breaking down its objectives, owners, methods, and best practices. Sales | What is REVIEWED BY: Jess Pingrey Jess served on the founding team of a successful B2B startup and has use...ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period.6.1%. 10% most volatile stocks in US Market. 15.2%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: ATRA is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 29% a week. Volatility Over Time: ATRA's weekly volatility has increased from 18% to 29% over the past year.Instagram:https://instagram. vtsax versus vfiaxarrived reviewnkla stockspenny stock trading app Goldman Sachs Sticks to Its Sell Rating for Atara Biotherapeutics (ATRA) November 9, 2023TipRanks. Atara Biotherapeutics downgraded to In Line from Outperform at Evercore ISI November 9 ...Nov 22, 2023 · According to analyst projections, ATRA’s forecast low is $0.50 with $28.00 as the target high. To hit the forecast high, the stock’s price needs a -5500.0% plunge from its current level, while the stock would need to tank 0.0% for it to hit the projected low. Atara Biotherapeutics Inc (ATRA) estimates and forecasts list of value stocksbest penny trading apps Neos Therapeutics, Inc. (NASDAQ:NEOS) posted its quarterly earnings results on Monday, November, 9th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.05) by $0.05. The firm earned $12.54 million during the quarter.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets. tltstock Atara Biotherapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Atara Biotherapeutics analysts is $ 14.72 . Today 200 Day Moving Average is the resistance level ( 2.335 $).Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.